OncoSec Medical, Inc.
| OTC Markets: ONCS
Similar to: EpiStem Holdings Plc
OncoSec Medical, Inc. is a drug-medical device company, which is focused on designing, developing and commercializing innovative and proprietary medical approaches for the treatment of solid cancers. Its business is composed of two different therapeutic modalities: ImmunoPulse DNA-based immunotherapy and NeoPulse therapy. ImmunoPulse and NeoPulse therapies address an unmet medical need and represent a potential solution, for less invasive and less expensive therapies that are able to minimize detrimental effects resulting from currently available cancer treatments such as surgery, systemic chemotherapy or immunotherapy and other treatment alternatives. The company core technology is based upon its proprietary use of an electroporation platform to dramatically enhance the delivery and uptake of a locally delivered DNA-based immunocytokine or chemotherapeutic agent. OncoSec Medical was founded by Avtar S. Dhillon and Punit S. Dhillon on February 8, 2008 and is headquartered in San Diego, CA.